Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01495
|
|||||
| Drug Name |
JNJ 7706621
|
|||||
| Synonyms |
JNJ-7706621; 443797-96-4; JNJ7706621; 4-((5-Amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl)amino)benzenesulfonamide; UNII-74GK72DON8; RWJ-387252; 4-[[5-amino-1-(2,6-difluorobenzoyl)-1,2,4-triazol-3-yl]amino]benzenesulfonamide; CHEMBL191003; 74GK72DON8; 4-[[5-Amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl]amino]benzenesulfonamide; JNJ 7706621; 4-(5-amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-ylamino)benzenesulfonamide
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Cancer [ICD11: 2A00-2F9Z] | Preclinical | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C15H12F2N6O3S
|
|||||
| Canonical SMILES |
C1=CC(=C(C(=C1)F)C(=O)N2C(=NC(=N2)NC3=CC=C(C=C3)S(=O)(=O)N)N)F
|
|||||
| InChI |
InChI=1S/C15H12F2N6O3S/c16-10-2-1-3-11(17)12(10)13(24)23-14(18)21-15(22-23)20-8-4-6-9(7-5-8)27(19,25)26/h1-7H,(H2,19,25,26)(H3,18,20,21,22)
|
|||||
| InChIKey |
KDKUVYLMPJIGKA-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 443797-96-4
|
|||||
| Pharmaceutical Properties | Molecular Weight | 394.4 | Topological Polar Surface Area | 154 | ||
| Heavy Atom Count | 27 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 10 | |||
| XLogP |
2.4
|
|||||
| PubChem CID | ||||||
| PubChem SID |
8036422
, 11062401
, 12015752
, 15174185
, 39303404
, 50100105
, 51710589
, 99437050
, 103459325
, 103905616
, 113916272
, 124756117
, 124757114
, 125163918
, 125749047
, 126728322
, 131480738
, 134343899
, 135685408
, 135685409
, 135685428
, 136340238
, 136367371
, 136367910
, 136920341
, 137275995
, 142802375
, 143498411
, 144116095
, 152234900
, 152258176
, 152344088
, 160647013
, 162011815
, 162037517
, 162202611
, 162527774
, 163410374
, 163848324
, 164193991
, 170482001
, 172113491
, 172914002
, 174561024
, 177748752
, 178102555
, 180386842
, 186007036
, 188899536
, 198980347
|
|||||
| ChEBI ID |
CHEBI:94506
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| References | ||||||
| 1 | SelleckChem-small molecule inhibitors & libraries: JNJ-7706621 | |||||
| 2 | Role of the ABCG2 drug transporter in the resistance and oral bioavailability of a potent cyclin-dependent kinase/Aurora kinase inhibitor. Mol Cancer Ther. 2006 Oct;5(10):2459-67. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.